Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. (Q48598645)
Jump to navigation
Jump to search
scientific article published in April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. |
scientific article published in April 2006 |
Statements
1 reference
Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. (English)
1 reference
Laurens V Beerepoot
1 reference
Sandra A Radema
1 reference
Els O Witteveen
1 reference
Tawnie Thomas
1 reference
Catherine Wheeler
1 reference
Sanford Kempin
1 reference
Emile E Voest
1 reference
1 April 2006
1 reference
24
1 reference
10
1 reference
1491-1498
1 reference